A prime example was given by estrogen receptor(s) in breast cancer patients and their molecular, cellular, and in vivo functions [2] both in rodent models and humans, as detailed in the current issue’s companion article (https://doi.org/10.3390/ijms241713661; accessed on 4 September 2023). Here, ESR1 is linked to breast carcinoma.